(Q36836699)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

The threat of avian influenza A (H5N1). Part IV: Development of vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

3

Hans W Doerr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

Jindrich Cinatl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

Medical Microbiology and Immunology

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

213-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00430-007-0052-3

31 December 2019

exact match

0 references

cites work

Trials of Influenza A/New Jersey/76 Virus Vaccine in Normal Children: An Overview of Age-Related Antigenicity and Reactogenicity

1 reference

https://api.crossref.org/works/10.1007%2FS00430-007-0052-3

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-007-0052-3

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-007-0052-3

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-007-0052-3

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

21 January 2018

1 reference

12 December 2020

Live attenuated versus inactivated influenza vaccine in infants and young children.

1 reference

12 December 2020

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

1 reference

12 December 2020

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

1 reference

12 December 2020

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

12 December 2020

Immunogenicity of novel consensus-based DNA vaccines against avian influenza.

1 reference

12 December 2020

Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.

1 reference

12 December 2020

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

1 reference

12 December 2020

Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets

1 reference

12 December 2020

Vaccine manufacturing: challenges and solutions

1 reference

12 December 2020

Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

1 reference

12 December 2020

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

1 reference

12 December 2020

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

1 reference

12 December 2020

Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.

1 reference

12 December 2020

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.

1 reference

12 December 2020

Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.

1 reference

12 December 2020

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

12 December 2020

Improvement of inactivated influenza virus vaccines

1 reference

12 December 2020

Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.

1 reference

12 December 2020

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

1 reference

12 December 2020

Avian influenza A (H5N1) infection in humans

1 reference

12 December 2020

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

1 reference

12 December 2020

1 reference

12 December 2020

Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA

1 reference

12 December 2020

Immunity to influenza in man

1 reference

12 December 2020

Development of effective vaccines against pandemic influenza.

1 reference

12 December 2020

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

1 reference

12 December 2020

Influenza: lessons from past pandemics, warnings from current incidents.

1 reference

12 December 2020

Cross-presentation in viral immunity and self-tolerance.

1 reference

12 December 2020

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

1 reference

12 December 2020

1 reference

12 December 2020

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

1 reference

12 December 2020

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

1 reference

12 December 2020

Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells

1 reference

12 December 2020

H5N1 influenza--continuing evolution and spread

1 reference

12 December 2020

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

1 reference

12 December 2020

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

1 reference

12 December 2020

Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection

1 reference

12 December 2020

Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model

1 reference

12 December 2020

The threat of avian influenza A (H5N1). Part III: Antiviral therapy.

1 reference

12 December 2020

Cytotoxic T-cell immunity to influenza.

1 reference

12 December 2020

Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans

1 reference

12 December 2020

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

1 reference

12 December 2020

Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses

1 reference

12 December 2020

Strategies for developing vaccines against H5N1 influenza A viruses.

1 reference

12 December 2020

Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process

1 reference

12 December 2020

The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology.

1 reference

12 December 2020

Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years

1 reference

12 December 2020

The annual production cycle for influenza vaccine

1 reference

12 December 2020

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

12 December 2020

Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.

1 reference

12 December 2020

The systemic and mucosal immune response of humans to influenza A virus

1 reference

12 December 2020

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

1 reference

12 December 2020

H5N1 viruses and vaccines

1 reference

12 December 2020

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

12 December 2020

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

12 December 2020

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

1 reference

12 December 2020

Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66.

1 reference

12 December 2020

Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines

1 reference

12 December 2020

Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.

1 reference

12 December 2020

Confronting the avian influenza threat: vaccine development for a potential pandemic.

1 reference

12 December 2020

Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic.

1 reference

12 December 2020

Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza

1 reference

12 December 2020

Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries?

1 reference

12 December 2020

Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.

1 reference

12 December 2020

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

1 reference

12 December 2020

CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.

1 reference

12 December 2020

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions

1 reference

12 December 2020

The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants.

1 reference

12 December 2020

Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats

1 reference

12 December 2020

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

1 reference

12 December 2020

Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?

1 reference

12 December 2020

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

1 reference

12 December 2020

H5N1 vaccines: how prepared are we for a pandemic?

1 reference

12 December 2020

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

12 December 2020

Development of vaccines against influenza H5

1 reference

12 December 2020

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

12 December 2020

Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950

1 reference

12 December 2020

Immunization of non-human primates with DNA vaccines

1 reference

12 December 2020

Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates

1 reference

12 December 2020

DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.

1 reference

12 December 2020

Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.

1 reference

12 December 2020

Human cytotoxic T-lymphocyte repertoire to influenza A viruses

1 reference

12 December 2020

Evidence for host-cell selection of influenza virus antigenic variants

1 reference

12 December 2020

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

1 reference

12 December 2020

Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge

1 reference

12 December 2020

Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition

1 reference

12 December 2020

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

1 reference

12 December 2020

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.

1 reference

12 December 2020

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

1 reference

12 December 2020

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

12 December 2020

Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model

1 reference

12 December 2020

Antibody response to the M2 protein of influenza A virus expressed in insect cells

1 reference

12 December 2020

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control

1 reference

12 December 2020

Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells

1 reference

12 December 2020

Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes

1 reference

12 December 2020

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

12 December 2020

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

1 reference

12 December 2020

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach

1 reference

12 December 2020

Influenza DNA vaccines

1 reference

12 December 2020

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

1 reference

12 December 2020

10.1007/S00430-007-0052-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541633%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference